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L. Winkle College of Pharmacy, University of Cincinnati Academic Health Center, Cincinnati, OhioABSTRACT Amicroscopic model of passive transverse mass transport of small solutes in the viable epidermal layer of human
skin is formulated on the basis of a hexagonal array of cells (i.e., keratinocytes) bounded by 4-nm-thick, anisotropic lipid bilayers
and separated by 1-mm layers of extracellular fluid. Gap junctions and tight junctions with adjustable permeabilities are included
to modulate the transport of solutes with low membrane permeabilities. Two keratinocyte aspect ratios are considered to repre-
sent basal and spinous cells (longer) and granular cells (more flattened). The diffusion problem is solved in a unit cell using a
coordinate system conforming to the hexagonal cross section, and an efficient two-dimensional treatment is applied to describe
transport in both the cell membranes and intercellular spaces, given their thinness. Results are presented in terms of an effective
diffusion coefficient, D
epi
, and partition coefficient, K
epi=w
, for a homogenized representation of the microtransport problem.
Representative calculations are carried out for three small solutes—water, L-glucose, and hydrocortisone—covering a wide
range of membrane permeability. The effective transport parameters and their microscopic interpretation can be employed
within the context of existing three-layer models of skin transport to provide more realistic estimates of the epidermal concen-
trations of topically applied solutes.INTRODUCTIONQuantitative understanding of the biophysics of drug/chem-
ical diffusion though the skin (1,2) is crucial to the effective
development of topically applied and transdermally deliv-
ered drugs (3,4), as well as assessment of risks associated
with chemical exposures (5,6). Theoretical models of
dermal absorption (7) can strongly support advancement
in these areas by providing mechanistic insights into solute
flux pathways, reasonable predictions of transdermal trans-
port rates and subsurface concentration levels, and a quanti-
tative framework to correlate experimental data and guide
measurements.
The most comprehensive modeling approach is based on
a two-scale strategy. At a macroscopic level of description,
the skin is broken down into stratum corneum (SC, barrier),
viable epidermis, and dermis layers (8–10). Each layer is
imbued with an effective partition coefficient K quantifying
solute affinity for the layer relative to an aqueous reference
solution, and an effective diffusion coefficient D. The
dermis is also described by one or more parameters quanti-
fying the rate of clearance from the tissue into the dermal
vasculature (8–12). Depending on the solute, all layers
may additionally be characterized in terms of an equilibrium
constant (or sorption isotherm) and/or rate constants for
reversible solute binding to tissue constituents (for instance,
keratin and other corneocyte constituents in the SC (13,14),
or albumin (11,12,15) and other binding/transporter proteins
(16,17) in the epidermis and dermis). Solution of the macro-Submitted November 11, 2012, and accepted for publication March 26,
2013.
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application of numerical techniques (7,10,14). The resulting
predictions are only as good as the effective tissue properties
input to the calculation.
Quantitative estimates of the effective tissue properties K
andD for a given solute can come, in turn, from microscopic
diffusion models that explicitly account for partitioning and
diffusion (and possibly also binding) within each phase of
some more or less idealized geometrical representation of
the heterogeneous microstructure (7,13,18–20). Ideally
such theoretical efforts should be calibrated against experi-
mental studies. In this regard, targeted measurements of
microscopic phase-specific properties (relatively few in the
literature) are ultimately more decisive than macroscopic
observations of overall absorption rates, in which amultitude
of factors express themselves in convoluted form. Given its
role as the primary and outermost barrier layer, it is not
surprising that the SC has attracted the most attention in
the form of microscopic brick-and-mortar models of SC
permeability (7,13,18–20). Cleek and Bunge (21) developed
a useful and influential description of the additional mass
transfer resistance contributed by viable tissue below the
SC, but it constitutes a lumped parameter (effective macro-
scopic) approach. A useful model has recently been devel-
oped to estimate partition and diffusion coefficients
specifically in the dermis from solute properties including
molecular weight (MW) and octanol/water partition coeffi-
cient (Koct/w) (11). There seems to be no detailedmicroscopic
diffusion model for the viable epidermis (henceforth distin-
guished here by the superscript epi) comparable to the
brick-and-mortar models of the SC. Formulation of such a
model yielding K
epi=w
and D
epi
is the objective of this work.http://dx.doi.org/10.1016/j.bpj.2013.03.056
2308 Nitsche and KastingLess is known about effective transport properties of the
epidermis than about those of the SC or dermis, because it
is difficult to isolate (8,22). Until now, a reasonable prag-
matic approach has been to treat the viable epidermis as
aqueous tissue roughly equivalent to dermis without any
vascular clearance in dermal diffusion models (8). This
approximation has minimal impact for the prediction of
systemic absorption rates because the resistance of the
viable epidermis is usually low relative to that of the SC.
However, it falls short in cases where strong penetration
into deeper tissue occurs (e.g., transdermal drug delivery
when the SC barrier has been seriously compromised by a
penetration enhancer (23)). It also does not suffice to model
actual solute concentrations within the epidermis, which is
critical for the quantitative mechanistic understanding of
epidermal bioavailability in the areas of topically applied
drugs (24) and contact allergy (9). Due to its viable cellular
structure, epidermis below the barrier layer presents a set of
obstacles to solute diffusion inherently different from those
of the SC and dermis. Transport through it involves a com-
bination of phenomena including:
1. Hindered permeant diffusion within cytoplasm relative
to bulk aqueous diffusion (25–27);
2. Cell wall permeation by transbilayer mass transfer
(19,28) in parallel with intercellular transfer via
epidermal gap junctions (GJ) (26,27,29–32);
3. Diffusion through extracellular fluid in the interstitial
space;
4. Barrier properties of tight junctions (TJ) (33–36);
5. Permeant binding to cellular structures, as well as to
albumin (11,12,15) and other binding/transporter proteins
(16,17) in both cytoplasm and extracellular fluid; and
6. Permeant metabolism (37,38).
Our analysis develops a basic microscopic diffusion
model that explicitly incorporates elements 1–4 within a
realistic unit cell of epidermal structure, and defines the
basic passive transport properties of viable epidermal tissue
for small solutes that are not excessively hydrophobic and
therefore not overly susceptible to protein binding. We
consciously choose to limit the scope of physical phenom-
ena addressed by presently not including items 5 and 6,
for two reasons. The first is that they are highly permeant-
specific. The second is that their inclusion for any specific
permeant requires a preliminary understanding of passive
transport per se, upon which these phenomena are super-
posed and from which they must be distinguished. Thus,
the first priority is to understand passive diffusion through
the cellular structure.
Our model is very similar in spirit to existing brick-and-
mortar models of the SC (7,13,18–20). Nothing precludes
this type of analysis from being applied to viable tissue,
and indeed, somewhat similar models exist for other tissues
of the body (27,39). The problem for analysis of epidermal
penetration is that the unit cells in such a model must beBiophysical Journal 104(10) 2307–2320carefully constructed to accurately reflect the specific attri-
butes of the real tissue, and this work just has not been
undertaken for the viable epidermis. It is important to distin-
guish this microscopic approach from coarse-grained
(macroscopic) models of epidermal transport (21) that
employ effective tissue properties but do not directly derive
their values from the microstructural physics.
The presentation is organized as follows. First we define
the model microstructure and equations governing solute
transport, and formulate a reasonable set of estimates for a
host of physicochemical parameters appearing therein.
Subsequent sections describe the analytical and numerical
procedures used to solve the model equations and derive
the effective transport coefficients, and analyze the results
to understand the key microscopic contributors to solute
flux. We close with a discussion of the elements needed
for broad practical application of the model, including
experimental studies for comprehensive parameterization
across a spectrum of permeants, and more permeant-specific
extensions to the effects of binding and metabolism.METHOD OF SOLUTION
Actual calculations are performed using a system of
horizontal coordinates x and f defined by the relations
x ¼ x;
y ¼ x tan f; (1)
which form the nonorthogonal mesh shown in Fig. 1 c. The
computation domain is defined by the intervals 0 % x %
xmax, 0 % f % fmax, and zmin % z % zmax. Direct use
of polar coordinates r ¼ (x2 þ y2)1/2, f ¼ arctan(y/x)
would be cumbersome because the cellular membrane is
situated at a variable (f-dependent) radius. Use of x and f
makes the membrane coincide with the coordinate surface
x ¼ xmax.
The unit cell diffusion problem, cast in terms of the vari-
ables x, f, and z, and written in a dimensionless form, is
solved by the method of finite differences coded in
Fortran 95. An illustrative coarse discretization of the
computational domain is shown from two perspectives in
Fig. 1, b and c. The integrals in Eq. 10 are evaluated numer-
ically using the calculated solute concentrations at the nodes
of the finite difference mesh. Significant aspects of the
mathematical formulation and computational scheme are
relegated to the Supporting Material for brevity here. The
computer code is available from the authors upon request.PROBLEM FORMULATION
Fig. 1 shows the assumed microstructural geometry. The
epidermal cell population (keratinocytes, melanocytes,
Langerhans cells) is represented by a single repeated struc-
ture considered to be a keratinocyte. This simplification
FIGURE 1 Assumed microstructure for the spinous layer. (A) Represen-
tation of a small section of tissue with two unit cells cut open. Node points
for a coarse finite difference discretization of the interior (cytoplasmic)
domain are shown within one unit cell; surface discretization points for
the bounding lipid membranes and layers of extracellular fluid are not
shown to avoid clutter. (B and C) Cross sections of one unit cell as seen
from top and side, respectively. The thickness of the lipid membranes is
exaggerated (not to scale) for visibility in all parts of the figure.
Diffusion Model of Viable Epidermis 2309suffices for a model limited to passive transport as there are
(to our knowledge) no documented differences in cellular
permeability and the keratinocyte is the predominate cell
type. Keratinocytes are idealized as hexagonal prisms
arranged in a hexagonal array within a given cellular layer,
and aligned in columns vertically. This assumption squares
with the roughly polyhedral shape evident in immunofluo-
rescence microscopy images of keratinocytes (29,32,35),
and their hexagonal shape as seen in cross section upon
migration to the surface (40). Based on the tightness of
the observed structure (32,35) and recent published concep-
tualizations (see Fig. 1 in Brandner (36) and Fig. 2 in
Tsukita and Furuse (33)), the amount of extracellular fluid
seems to be small, and so is represented in terms of thin
aqueous films separating adjacent keratinocytes. Tight junc-
tions appear in Fig. 1 as effective barriers interrupting these
liquid films, asymmetrically located nearer the tops than the
bottoms of the keratinocytes (33,36). We focus on neutral
permeant molecules, or the unionized (neutral) form of
ionizable permeants, because the approach to treating ioni-
zation is well established (41).Overall approach
Our objective is a rigorous calculation of the effective diffu-
sivity D
epi
for vertical (transdermal or z-directed) motion
through the structure shown. For purposes of this calcula-
tion, the structure is regarded as an infinite medium extend-
ing indefinitely in all directions including the vertical.
Clearly, in subsequently using the effective diffusivity in
an absorption calculation at the macroscopic scale, the
epidermis has a finite thickness.
Substrata of the viable epidermis differ significantly in
terms of the aspect ratio of keratinocytes, metabolic and
other processes, and occurrence of tight junctions. There-
fore, we develop two variants of the model, respectively
geared toward representing tissue of the spinous and gran-
ular layers, and ultimately envision use of the model in a
two-layer macroscopic representation of the epidermis.
The basal layer is combined with the spinous layer in this
description as the higher aspect ratio for the single layer
of basal cells (42) is inconsequential to passive permeability,
as will be shown.
Use of the effective (coarse-grained) value of D
epi
calcu-
lated for each substratum constitutes a reasonable approxi-
mation in a macroscopic model, because the substratum
comprises several layers of keratinocytes—typically three
for the granular layer, and three or more for the spinous
layer (33,42).Geometry
The side length (‘side) and height (‘height) of the hexagonal
prisms representing the cytoplasm of keratinocytes are re-
garded as adjustable parameters, as are the thicknesses ofBiophysical Journal 104(10) 2307–2320
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fluid separating neighboring keratinocytes (sext). Nominal
values of these (and other) parameters are listed in Table 1.
Given the spatial periodicity of the structure, it suffices to
consider only one unit cell (say that centered at (x, y, z) ¼
(0,0,0) for definiteness), and considerations of symmetry
indicate that the unit-cell transport problem need only be
posed and solved in 1/12th of this unit cell (i.e., a sector
of the horizontal cross section spanning an angle of fmax ¼
30). The computational domain in the xy plane (Dxy)
considered for the cytoplasm is therefore as shown in
Fig. 1 B. The coordinate x runs from 0 to xmax (with
xmax ¼ ðcos fmaxÞ‘side ¼ ð
ﬃﬃﬃ
3
p
=2Þ‘side), and z runs from
zmin to zmax (with zmax ¼  zmin ¼ ‘height/2). The vertical
period of the structure,
‘period ¼ ‘height þ 2slip þ sext; (2)
differs little from the height ‘height of the cytoplasm of one
keratinocyte owing to thinness of the lipid and extracellular
fluid phases.
For the spinous layer the numerical values of ‘side
and ‘height in Table 1 imply a keratinocyte diameter of
~23 mm, which seems to be broadly consistent with various
microscopic images (29,32,35,40). They are determined as
the unique pair of values consistent with both a unit aspect
(height/width) ratio and a nominal ~2500 mm2 membrane
area. This area estimate is based on the notion of approxi-
mate conservation of surface area as keratinocytes termi-
nally differentiate (because they had to build the scaffold
for the cornified cell envelope while living), together withTABLE 1 Assumed dimensions quantifying keratinocyte geometry
input parameters for the diffusion model
Microscopic tissue attribute, phase, or element
Geometry
Cytoplasm
Dcy
Extracellular fluid
Dext ¼
Lipid (see the Supporting Material)
Dli
Gap junctions (see the Supporting Material)
kGJ ¼

5 107 cm
5 108 cm
Tight junctions
kTJ ¼

MW denotes molecular weight and Koct/w denotes octanol/water partition coeffic
Daq of the solute, and its permeability coefficient PDMPC/w through DMPC bilay
Biophysical Journal 104(10) 2307–2320knowledge of the final shapes (which are roughly hexagonal
corneocytes with a diameter of ~40 mm and a thickness of
0.8–1 mm). Keratinocytes in the stratum granulosum tend
to be partially flattened, as illustrated nicely in Fig. 2 of
Tsukita and Furuse (33). The nominal dimensions in Table 1
decrease the aspect ratio to 0.5 for this layer.
The value slip ¼ 4 nm agrees with a recent visualization
of viable epidermis by cryo-electron microscopy (43), in
which ‘‘[t]he plasma membranes appear as ~4 nm thick
high-density double-layer patterns.’’
The average thickness sext ¼ 1 mm of the layers of extra-
cellular fluid separating keratinocytes may ultimately be
fixed partly by matching permeability data for hydrophilic
permeants (see Discussion). The value assumed here is the
order of magnitude that is consistent with apparent thinness
relative to the keratinocyte diameter, yet also produces a
significant (~12%) extracellular fluid volume fraction
(compare to an anecdotal estimate of 20% (44)).Governing transport equations
Calculation of the effective diffusivity requires the solution
of a well-defined steady-state diffusion problem in the unit
cell. Solute transport within the cytoplasm is described by
the equation (19,26,27)
V$ðDcytVCcytÞ ¼ 0 (3)
governing the solute concentration Ccyt, in which appears
the diffusion coefficient Dcyt (cm2/s) quantifying hindered
aqueous diffusion through the cytoplasm. For lack of more, and formulas providing provisional values of microscopic
Formula
‘side ¼

12:4 mm ðstratum spinosumÞ
15:3 mm ðstratum granulosumÞ
‘height ¼

23 mm ðstratum spinosumÞ
14 mm ðstratum granulosumÞ
slip ¼ 0:004 mm
sext ¼ 1:0 mm
Kcyt=w ¼ 0:6
t ¼ Daq=Hcyt; Hcyt ¼ 3 ðhindrance factor for cytoplasmÞ
Kext=w ¼ 0:6
Daq=Hext; Hext ¼ 2 ðhindrance factor for extracellular fluidÞ
Klip=w ¼ 1:25 Koct=w
p ¼ ð1:58 103 cm2=sÞMW1:69 þ 8:34 108 cm2=s
ktrans ¼ 2 PDMPC=w=Klip=w
=s ðlower boundÞ; 5 104 cm=s ðupper boundÞ ðstratum spinosumÞ
=s ðlower boundÞ; 5 105 cm=s ðupper boundÞ ðstratum granulosumÞ
N ðno seal; appropriate for stratum spinosumÞ
0 ðperfect seal; maximum barrier for stratum granulosumÞ
ient of the solute. Required transport properties are the aqueous diffusivity
ers. A full explanation of the formulas is given in the Supporting Material.
Diffusion Model of Viable Epidermis 2311detailed information about transport properties of the cyto-
plasm (see below), we regard the keratinocyte interior as
a homogenous effective medium characterized by a suitable
average value of Dcyt, following common practice (25–27),
which reduces Eq. 3 to the Laplace equation.
Transport in the lipid phase occurs by processes illus-
trated in Figs. 2 and 3. Given its thinness, we idealize the
solute distribution within this phase in terms of effectively
two-dimensional distributions of concentration repre-
senting averages over the bilayer cross section (Clip(y,z)
for the vertical section of membrane in Fig. 3, and Clip(x,y)
for the horizontal section). This surface description has pre-
cedent in some brick-and-mortar models of SC perme-
ability (19), and can be put on a rigorous asymptotic
foundation (J. M. Nitsche, unpublished result). Motion
parallel to the plane of the bilayer occurs by lateral diffu-
sion, quantified by a diffusivity Dlip. Perpendicular solute
transfer to or from the bilayer is described by a mass trans-
fer coefficient ktrans referred to lipid-phase concentrations
(19,28). It represents the constant of proportionality
between flux past the headgroups and through the barrier
(ordered acyl-chain) region (45) to the center of the bilayer,
and the lipid-phase concentration difference driving this
flux. (The coefficient ktrans as defined here is equivalent
to 2k0 and 2ktrans in the notation of Johnson et al. (28)
and Wang et al. (19), respectively.) The surface transport
equation for the lipid phase necessarily involves the cyto-
plasm on one side and the extracellular fluid on the other
side, because these phases represent the sources from
which solute enters the bilayer perpendicularly, as
described by the equation (19)FIGURE 2 Mechanisms of transport along and through interfaces of the
structure shown in Fig. 1. (Solid arrows) Lateral diffusion along the lipid
cell membrane in both horizontal (from point A to B) and vertical (from
B to C) sections of the membrane. (Dotted arrows) Perpendicular transfer
between the cytoplasm or extracellular fluid and the lipid membrane.
(Outlined open arrow) Direct intercellular diffusion pathway mediated by
gap junctions.slipDlipV2sClip ¼ ktrans

Ccyt
Kcyt=lip
 Clip

þ

Cext
Kext=lip
 Clip

(4)
(see Fig. 3). Here Kcyt/lip and Kext/lip, respectively, denote the
cytoplasm/lipid and extracellular fluid/lipid partition coeffi-
cients. We adopt the convention of defining partition coeffi-
cients for each phase relative to a reference aqueous solution
w, i.e., Klip/w, Kcyt/w, and Kext/w. In terms of them, the two
partition coefficients appearing in Eq. 4 are given by the
ratios Kcyt/lip ¼ Kcyt/w/Klip/w and Kext/lip ¼ Kext/w/Klip/w.
The symbol V2s denotes the two-dimensional (surface) Lap-
lacian operator, i.e., V2yz ¼ v2=vy2 þ v2=vz2 for the vertical
section of membrane in Fig. 3, and V2xy ¼ v2=vx2 þ v2=vy2
for the horizontal section. The two terms in parentheses
on the right-hand side of Eq. 4 represent solute influx to
the bilayer from the cytoplasm and the extracellular fluid,
indicated with dotted arrows and underlines in the figure.
There is no literal belief that the cellular membrane
actually possesses crisp edges (sharp corners seen in cross
section) in transitioning from horizontal to vertical sections,
i.e., the actual membrane turns with a finite radius of curva-
ture. We ensure physical realism by stipulating that the
corners in the model do not impede lateral diffusion of the
solute, indicated with solid arrows in Fig. 2. Thus, for
instance, the flux from point A to B must match that from
B to C. The mathematical statement of this requirement is
given in the Supporting Material.
Thinness of the layers of extracellular fluid separating
apposed sections of cellular membranes implies that they
can be treated by the same type of two-dimensional
formalism used for the lipid phase, albeit with markedly
different properties. The equation analogous to Eq. 4
governing the solute concentration field Cext is given in
the Supporting Material.
Tight junctions produce a zone of kissing points between
apposed vertical sections of cellular membranes that inter-
rupts the vertical extracellular route of transport with a
more or less tight (impermeable) seal. This zone is located
near the apical (upper) extreme of the lateral membrane
(33,36).We do not attempt to describe literally the associated
undulations in the membrane contour. The overall effect is
represented rather by an effective barrier (depicted as a
cross-hatched plug in Fig. 2) located at an elevation zTJ
and characterized by a mass transfer coefficient kTJ depen-
dent on the effective permeability of the microscopic struc-
ture. This coefficient appears in the interfacial condition
Dext
vCext
vz

y; zTJþ
	 ¼ DextvCext
vz

y; zTJ
	
¼ kTJ
Cexty; zTJþ 	 Cexty; zTJ 	; (5)
in which the symbols zTJþ and z
TJ
 are used to denote limiting
values as one approaches the barrier from above and below.Biophysical Journal 104(10) 2307–2320
FIGURE 3 Illustration of Eqs. 4 and 6. (Dotted
arrows/underlines) Solute influx to the bilayer from
the cytoplasm and the extracellular fluid for an
application of Eq. 4 at the vertical boundary of the
cytoplasm in the computational domain. (Dotted and
outlined white arrows/underlines) Solute flux out of
the cytoplasm through the membrane and through
gap junctions, respectively, for an application of
Eq. 6 at the upper horizontal boundary.
2312 Nitsche and KastingAside from transbilayer transport, an additional
mechanism exists for intercellular solute transfer, namely
the direct route provided by epidermal gap junctions
(26,27,29–32); see outlined open arrows in Figs. 2 and 3.
The level of detail of our analysis does not support a literal
accounting for variations in the thickness of the extracellular
fluid layers resulting from the touching of cellular mem-
branes at junctions or in junctional plaques. Thus, our
assumed layer thickness sext represents an average value.
The overall expression of junctional permeability is a
surface-average mass transfer coefficient kGJ.
Both ktrans and kGJ appear in the boundary condition on
Ccyt quantifying normal solute flux at the cellular mem-
brane, namely
Dcytn$VCcyt ¼ ktrans

Ccyt
Kcyt=lip
 Clip

þkGJðCcyt  Ccyt;aÞ;
(6)
in which Ccyt,a denotes the local cytoplasmic concentration
of solute in the neighboring keratinocyte. The outward
normal derivative n $ V is equivalent to v/vx on the vertical
boundary of the cytoplasmic domain in Fig. 3, v/vz on the
upper horizontal boundary, and v/vz on the lower horizon-
tal boundary (not included in the figure).Effective transport properties
For convenience, we introduce the symbol K/w(x,y,z) to
denote the piecewise constant, periodic function of position
equal to Ka/w for positions (x, y, z) lying in phase a (a¼ cyt,
lip, or ext) (19). The macroscopically observable effective
partition coefficient is simply its unit-cell (volume) average
(18,19),Biophysical Journal 104(10) 2307–2320K
epi=w ¼ K=w ¼ VcytKcyt=w þ V lipKlip=w þ VextKext=w
Vcyt þ V lip þ Vext ; (7)
in which Vcyt, Vlip, and Vext denote the volumes of the cyto-
plasmic, lipid membrane, and extracellular fluid phases in
one unit cell.
We utilize a classical steady-state formalism (19,46) to
calculate the effective diffusivity D
epi
. As discussed in the
Supporting Material, this method is equivalent to homogeni-
zation methods that have been applied in microscopic
diffusion models of the SC (20,47,48). The overall idea is
to calculate the transdermally (z-) directed flux of solute
resulting from the imposition of a z-directed gradient in its
concentration. This procedure yields D
epi
as the constant
of proportionality between average flux and concentration
gradient. The diffusion problem embodied in Eqs. 3–6
(together with additional equations in the Supporting
Material) is posed subject to the periodicity-type condition
(19,46)
C

x; y; zþ ‘period
	 ¼ Cðx; y; zÞ þ C0K=wðx; y; zÞ: (8)
Here C(x, y, z) is a collective symbol denoting Ca(x, y, z) for
positions (x, y, z) lying in phase a, and C0 is an arbitrary
constant with dimensions of concentration (which can be
set to unity without loss of generality). Equation 8 corre-
sponds to a macroscopically linear variation in volume-
average concentration possessing a gradient (19,46)
vC=vz ¼ C0K
epi=w
‘period
: (9)
The average transdermally (z-directed) solute flow
through any horizontal cross section of the unit cell must
Diffusion Model of Viable Epidermis 2313be the same by mass conservation. Dividing the flow
through the plane z ¼ 0, say, by the cross-sectional area
jDxyj gives this macroscopically observable solute flux:
Jz ¼
Dxy1
RR
Dcytxy D
cytvC
cyt
vz
ðx; y; 0Þdxdy
þ slip R ‘side=2
0
Dlip
vClip
vz
ðy; 0Þdy
þ s
ext
2
Z ‘side=2
0
Dext
vCext
vz
ðy; 0Þdy

:
(10)
As written, this formula is formulated in terms of the
reduced computational domain Dxy shown in Fig. 1 B.
The effective diffusivity is calculable from the results of
Eqs. 9 and 10 as the ratio
D
epi ¼ Jz
vC=vz
: (11)
MODEL PARAMETERS
Innumerable microscopic structural details of the epidermis
are known and have been presented in exquisite detail (42)
(see also the various microscopy studies cited above
(29,30,32,35,36)). In contrast, we are unaware of any
reported data on partition and diffusion coefficients of indi-
vidual microscopic phases of viable human epidermis for
any solute. All of the quantities Klip/w, Dlip, ktrans, Dcyt,
Kcyt/w, Dext, Kext/w, kGJ, and kTJ are measureable in principle
(in many cases with considerable difficulty), either directly
or indirectly, but are presently unknown. Such detailed,
microscopic, phase-specific information is distinct from:
1. Effective solute partition and diffusion coefficients for
viable epidermis, and
2. Overall dermal absorption rates.
Item 1 represents an average over the microscopic quanti-
ties, which is precisely what we undertake to calculate
theoretically in this article. Even such data are extremely
scarce. Nitsche and Kasting (8) review some available infor-
mation, which is anecdotal at best. It is this type of informa-
tion with which results of our model should ultimately
be compared. Item 2 represents a further convolution of
epidermal properties within the overall outcome of diffusion
through the epidermis in series with the SC and dermis.
In the face of this dearth of information, we formulate
in Table 1 reasonable provisional estimates based on con-
temporary knowledge of hindered aqueous mobility in cyto-
plasm and extracellular fluid (25–27), and mobility
properties of phospholipid bilayer membranes (49), as is
explained in detail in the Supporting Material. The required
inputs for any given solute are its molecular weight (MW),
octanol/water partition coefficient (Koct/w), aqueous diffu-
sivity at 37C (Daq), and permeability coefficient for passivediffusion through pure dimyristoylphosphatidylcholine
(DMPC) bilayers at 37C (PDMPC/w). Considerable effort
went into the development of general equations to estimate
Klip/w, Dlip, and ktrans, based on a comprehensive assessment
of the literature on partition and permeability coefficients as
well as fatty-acid chain density of phospholipid bilayers
(49). Use of DMPC as the basis for modeling keratinocyte
membranes is justified in detail in the Supporting Material.
We ultimately judge the estimates in Table 1 by compar-
ison of model results with approximate expectations for the
average properties of epidermal tissue (8). Part of the value
of a detailed microscopic model is that it lays bare all the
areas where measurements are needed. It can also help to
guide and prioritize experiments by revealing which param-
eters seem to be the most important determinants of solute
flux or epidermal concentration levels based on preliminary
estimates.
The level of ambiguity inherent in some parameters is so
great that they are best quantified in terms of upper and
lower bounds. The data and logical arguments leading to
the bounds on the gap junctional permeability coefficient
kGJ listed in Table 1 are presented in detail in the Supporting
Material. Available knowledge on tight junctions (33–36)
simply does not support any quantitative microscopic pore
model or specific numerical values of the permeability
coefficient kTJ. Therefore, we adopt the strategy of restrict-
ing numerical calculations to the two extremes of no seal
(kTJ/N) or a perfect seal (kTJ/ 0) between adjacent ker-
atinocytes. Tight junctions occur primarily in the granular
layer (33,36). The perfect-seal limit provides an upper
bound on the barrier properties of this layer. The no-seal
limit offers a representation of the spinous layer.
Calculations are carried out for three illustrative perme-
ants, namely water (regarded as a tracer species), L-glucose,
and hydrocortisone. (L-Glucose is a largish hydrophilic
molecule behaving as a nonmetabolized, passively trans-
ported solute. As such, it is on the same footing as the other
two permeants. It characterizes the intrinsic mobility prop-
erties of the physiologically relevant D stereoisomer with
all biochemical mechanisms for metabolism and active
transport effectively switched off.) Numerical values of all
model parameters for these three compounds, resulting
from the formulas in Table 1, are listed in Table 2.RESULTS
Results stated here have the significance of rigorously calcu-
lated outcomes of the model predicated on the assumed
microscopic geometry and physicochemical parameter
values.Effective partition coefficient
Table 3 presents a breakdown of K
epi=w
into contributions
from occupancy of the cytoplasmic (cyt), membrane (lip),Biophysical Journal 104(10) 2307–2320
TABLE 2 Physical input properties (MW, log10 K
oct/w, Daq,
PDMPC/w) and estimated model parameters for water, L-glucose,
and hydrocortisone
Property Water L-glucose Hydrocortisone
MW 18.015 180.16 362.46
log10 K
oct/w 1.38 3.24 1.61
Daq 3.3  105 cm2/s 1.0  105 cm2/s 5.8  106 cm2/s
PDMPC/w 3.7  103 cm/s 4.0  1011 cm/s 5.0  104 cm/s
Kcyt/w 0.60 0.60 0.60
Dcyt 1.10  105 cm2/s 3.33  106 cm2/s 1.93  106 cm2/s
Kext/w 0.60 0.60 0.60
Dext 1.65  105 cm2/s 5.00  106 cm2/s 2.90  106 cm2/s
Klip/w 5.21  102 7.19  104 5.09  101
Dlip 1.20  105 cm2/s 3.27  107 cm2/s 1.58  107 cm2/s
ktrans 1.42  101 cm/s 1.11  107 cm2/s 1.96  105 cm/s
kGJ See Table 1
kTJ See Table 1
Kcyt/wDcyt/
(20 mm)
3.30  103 cm/s 1.00  103 cm/s 5.80  104 cm/s
Klip/wktrans/4 1.85  103 cm/s 2.00  1011 cm/s 2.50  104 cm/s
Kext/wDext/
(1 mm)
9.90  102 cm/s 3.00  102 cm/s 1.74  102 cm/s
2314 Nitsche and Kastingand extracellular fluid (ext) phases. The results are under-
standable from the structure, which comprises 87.9%
cytoplasm, 0.1% lipid, and 12.0% extracellular fluid by
volume for stratum spinosum. (The fractions differ little
from these values for stratum granulosum.) On top of the
small volume fraction of lipid, unfavorable partitioning
makes lipid-phase holdup truly negligible for hydrophilic
solutes like water and L-glucose. In contrast, high lipophi-
licity can compensate partly for the small lipid volume
fraction, to the extent that ~8% of hydrocortisone partitions
into the lipid phase. It is fair to say that K
epi=w
will usually
be a number of the order of unity, excepting highly lipo-
philic species.Effective diffusivity
Calculated results for D
epi
are presented in Tables 4–6. The
first two are geared toward comparisons of D
epi
among
the three representative solutes considered, and among the
four possible cases considered (involving choices of upper-TABLE 3 Tissue-average (effective) partition coefficient
K
epi=w
and phase-specific breakdown of solute holdup
Stratum Solute K
epi=w
% of Holdup
Cyt Lip Ext
Spinous Water 0.599 88.0 8  103 12.0
L-glucose 0.599 88.0 1  104 12.0
Hydrocortisone 0.648 81.3 7.6 11.1
Granular Water 0.599 87.2 9  103 12.8
L-glucose 0.599 87.2 1  104 12.8
Hydrocortisone 0.652 80.2 8.0 11.8
The abbreviations cyt, lip, and ext denote cytoplasm, lipid membrane, and
extracellular fluid, respectively.
Biophysical Journal 104(10) 2307–2320or lower-bound values of kGJ and kTJ). The last offers
a more detailed mechanistic breakdown of D
epi
for the
spinous layer, with kTJ / N, for both upper- and lower-
bound values of kGJ.
Diffusion through the assumed periodic structure is an
inherently three-dimensional process not amenable to
representation by any simple analytical formulas (which is
precisely the reason necessitating a detailed numerical
model). Nevertheless, for physical understanding it is
worthwhile to introduce a very approximate decomposition
in terms of two parallel pathways considered additively:
1. A hypothetical transcellular pathway that alternates
between ~20-mm-thick cytoplasmic layers, ~1-mm-thick
layers of extracellular fluid, and cellular membranes; and
2. A pathway that involves diffusion vertically through
thin-walled hexagonal cylinders of extracellular fluid,
which cover ~9% of the area fraction in a typical
cross section.
We shall refer to these hypothetical pathways as the trans-
cellular and extracellular pathways, respectively, with the
understanding that they represent approximate concepts.
(An analogous lipid pathway for diffusion along the cell
membranes is not worth introducing because of its truly
negligible contribution to the total solute flow—see below.)
The combinations of parameters included at the bottom of
Table 2 represent mass transfer coefficients (operative in
series, and referred to concentrations in aqueous solution
w) that would characterize the cytoplasmic, extracellular,
and lipid phases of the transcellular pathway. They are
useful for subsequent discussion of D
epi
.
One of the two breakdowns presented in Table 6 is the
distribution among the contributions to vertical diffusive
flow of solute through the horizontal cross section at
z ¼ 0 from the three phases (cyt, lip, and ext), cor-
responding to the three respective terms in Eq. 10. For
hydrocortisone it shows that the majority of solute flow
occurs in the aqueous (cyt, ext) compartments. The lipid
phase is so thin that diffusion in the plane of the membrane
accounts for only 0.5% of the total flow, despite significant
occupancy of this phase (~8%). For hydrophilic compounds
like water and L-glucose, the lipid contribution is even
smaller. Thus, the lateral diffusivity Dlip is essentially irrel-
evant to transepidermal transport. The other breakdown in
Table 6 applies only to transport into the cytoplasm at the
top of the cell (z ¼ ‘height/2). Solute from the cytoplasm
above can enter directly via the gap junctional pathway,
controlled by kGJ. It can also follow a transmembrane
pathway passing through a phospholipid barrier region
four times (passing through two cell membranes) controlled
by ktrans.
Lipophilic compounds tend to be adept at passing through
lipid membranes, owing primarily to favorable partitioning
(which elevates in-membrane concentration levels, and
thereby, flux). The intrinsic membrane permeability of the
TABLE 4 Values of the effective (tissue-average) diffusion coefficient D
epi
calculated for various scenarios with different values of
kGJ and kTJ, expressed in absolute terms in units of cm2/s
Stratum Solute
D
epi
in cm2/s for case
kGJ high, kTJ/N
D
epi
in cm2/s for case
kGJ high, kTJ ¼ 0
D
epi
in cm2/s for case
kGJ low, kTJ/N
D
epi
in cm2/s for case
kGJ low, kTJ ¼ 0
Spinous Water 6.8  106 6.3  106 6.5  106 6.0  106
L-glucose 1.3  106 8.2  107 4.5  107 1.1  109
Hydrocortisone 1.2  106 1.1  106 9.6  107 8.7  107
Granular Water 5.0  106 4.3  106 5.0  106 4.3  106
L-glucose 4.5  107 6.9  108 3.8  107 7.0  1011
Hydrocortisone 7.5  107 6.3  107 7.2  107 6.0  107
The identifiers kGJ high and kGJ low, respectively, represent the upper- and lower-bound values of kGJ listed in Table 1 for each stratum. The cases kGJ high,
kTJ/N and kGJ low, kTJ/N for the spinous layer are singled out in boldface for more detailed consideration in Table 6. The cases with kTJ ¼ 0 for the
spinous layer are hypothetical (i.e., not physically representative) because tight junctions occur primarily in the granular layer (33,36).
Diffusion Model of Viable Epidermis 2315moderately lipophilic compound hydrocortisone is already
sufficiently high for:
1. Even the upper-bound value of kGJ to provide little more
than half of the solute flow into the top of the cytoplasm;
and
2. The two cell membranes (i.e., four phospholipid barrier
regions) in one unit cell to present only about twice as
much mass transfer resistance as diffusion through
the cytoplasm (specifically, (Klip/wktrans/4)1 ¼ 2.3
[Kcyt/wDcyt/(20 mm)]1 based on the numbers in Table 2).
For more highly lipophilic compounds, the cytoplasm
would, in fact, present the dominant mass transfer resistance
in the transcellular pathway. It follows that D
epi
for highly
lipophilic compounds reflects mostly Dcyt (equivalent to
Daq modified by a hindrance factor here called Hcyt), a
conclusion that accords with the concept enunciated long
ago (50) that tissue below the stratum corneum presents a
primarily aqueous barrier to dermal penetration for such
species. The extracellular pathway is a minor contributor
to D
epi
because it operates over a minority (~9%) of the
tissue area. For this reason, even a complete choking off
of this pathway (kTJ¼ 0) has a minor effect (Tables 4 and 5).
In contrast, a large hydrophilic compound like L-glucose
has such a low intrinsic membrane permeability that gap
junctions represent the dominant means of intercellular
transfer. Membrane permeation by this junctional mecha-
nism is the rate-limiting step in the transcellular pathway,TABLE 5 Values of the effective (tissue-average) diffusion coefficie
kGJ and kTJ, expressed relative to the aqueous diffusivity, i.e., given
Stratum Solute
D
epi
=Daq for case
kGJ high, kTJ/N
D
kG
Spinous Water 0.20
L-glucose 0.13
Hydrocortisone 0.21
Granular Water 0.15
L-glucose 0.045
Hydrocortisone 0.13
The identifiers kGJ high and kGJ low, respectively, represent the upper- and lowe
kTJ/N and kGJ low, kTJ/N for the spinous layer are singled out in boldfac
spinous layer are hypothetical (i.e., not physically representative) because tightbecause the mass transfer resistance for this step (3.3 
103 s/cm < (Kcyt/wkGJ)1 < 3.3  106 s/cm) is larger than
that for diffusion through the cytoplasm ([Kcyt/wDcyt/
(20 mm)]1 ¼ 1.0  103 s/cm). Thus, the transcellular
pathway is controlled by kGJ. At the upper-bound value of
kGJ, it provides 65% of the L-glucose flow, whereas at the
lower-bound value, it is effectively shut down. In the latter
case, the extracellular pathway assumes responsibility for
essentially all (99.8%) of the L-glucose flow through
the spinous layer, D
epi
coming out to 4.5  107 cm2/s
(Table 4). (This value is, in fact, predictable a priori.
Indeed, the operative diffusivity isDext, and diffusion occurs
over ~9% of the area of a typical cross section. The numer-
ical value 0.09  Dext exactly matches Depi.) If the extracel-
lular pathway is now choked off by a hypothetically perfect
tight junctional seal (kTJ ¼ 0), then the effective diffusivity
drops to the meager level (1.1 109 cm2/s) afforded by the
low kGJ.DISCUSSION
The average epidermal partition coefficient offers no real
surprises because it is primarily a reflection of bookkeeping
on the volume fraction and hydro/lipophilicity of each
constituent phase (Eq. 7). The dynamics of diffusion is
considerably more complex (see Eqs. 3–6 and 8–11, and
additional equations in the Supporting Material). Broadly
speaking, the most significant finding is that calculatednt D
epi
calculated for various scenarios with different values of
as the ratio D
epi
=Daq
epi
=Daq for case
J high, kTJ ¼ 0
D
epi
=Daq for case
kGJ low, kTJ/N
D
epi
=Daq for case
kGJ low, kTJ ¼ 0
0.19 0.20 0.18
0.082 0.045 1.1  104
0.19 0.17 0.15
0.13 0.15 0.13
0.0069 0.038 7.0  106
0.11 0.12 0.10
r-bound values of kGJ listed in Table 1 for each stratum. The cases kGJ high,
e for more detailed consideration in Table 6. The cases with kTJ ¼ 0 for the
junctions occur primarily in the granular layer (33,36).
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TABLE 6 Mechanistic breakdownofD
epi
for the spinous layer,with kTJ/N, for upper- and lower-bound valuesof kGJ (5 104 cm/s
and 5  107 cm/s, respectively)
Solute kGJ, cm/s
% of total solute flow through cross section halfway up cell
(z ¼ 0)
% of solute flow into top of keratinocyte
(z ¼ ‘height/2)
Cyt Lip Ext from ktrans from k
GJ
Water 5  104 (high) 85 0.007 15 85 15
5  107 (low) 85 0.007 15 99.98 0.02
L-glucose 5  104 (high) 65 z0 35 z0 100
5  107 (low) 0.2 z0 99.8 0.004 99.996
Hydrocortisone 5  104 (high) 84.6 0.5 14.9 43 57
5  107 (low) 82.5 0.5 17 99.9 0.1
2316 Nitsche and Kastingvalues of D
epi
for water and hydrocortisone are typically
10–20% of Daq:
D
epi ¼ D
aq
Hepi
; Hepiz5 to 10: (12)
Interestingly, this provisional theoretical conclusion accords
with the limited anecdotal evidence that is available (see,
e.g., the brief review given in Nitsche and Kasting (8)).
Thus, for instance, Bunge and Cleek (51) suggested a
hindrance factor of about an order of magnitude relative
to bulk aqueous diffusion based on measurements by Tojo
and Lee (52). We did not adjust any model parameters
with the aim of arriving at what seems to be the correct order
of magnitude for D
epi
. Rather, we made the best possible a
priori estimates of all unknown parameters (provisional
values in Table 1), and then observed the logical outcome
from a rigorous analysis of the microscopic multiphase
transport equations.Mechanistic conclusions
It is worthwhile to highlight the dominant transport mecha-
nisms underlying the quantitative outcomes for D
epi
, and
the priorities they suggest for experimental clarification.
The theoretical considerations presented above regarding
lipophilic permeants suggest the approximate relation
D
epi
zDcyt ¼ D
aq
Hcyt
ðhighly lipophilic permeantsÞ; (13)
which speaks for further understanding of cytoplasmic
mobility, given its role as the primary determinant of
average epidermal mobility. The extracellular pathway is a
minor player, which makes the whole issue of tight junc-
tional barrier properties a moot point. High transmembrane
permeability tends to make also kGJ a largely irrelevant fac-
tor. For highly lipophilic permeants (i.e., those with log
Koct/wR 3), however, the role of binding to diffusible pro-
teins both intracellularly and extracellularly cannot be
ignored (12). Thus, a further theoretical development ac-
counting for binding would be needed to actually use this
model for such permeants.Biophysical Journal 104(10) 2307–2320For large hydrophilic, passively-transported permeants
like L-glucose (which are very membrane impermeable),
we conclude that
D
epi
z
(ð20 mmÞkGJ ¼ 1 106 cm2=s ðkGJ highÞ
ð0:09ÞDext ¼ ð0:09ÞDaq=Hext ðkGJ lowÞ
ðlarge hydrophilic permeantsÞ:
(14)
At the upper bound of gap junctional permeability, the
value of kGJ directly controls D
epi
as the rate-limiting
element of the transcellular pathway. At the lower bound
of kGJ, the primary pathway seems to be extracellular
in the absence of a significant tight junctional barrier
(spinous and basal layers). This finding underscores the
importance of:
1. Quantifying solute mobility in extracellular fluid;
2. Carefully calibrating the volume fraction of extracellular
fluid, which underlies the numerical coefficient 0.09; and
3. Characterizing tight junctions, which more or less
completely choke off the extracellular pathway in the
granular layer.
Equation 14 is consistent with the results of Khalil et al.
(22), who present three determinations of D
epi
for glucose,
namely (3.7 5 1.9)  108 cm2/s, (7.5 5 5.0)  108
cm2/s, and (1.0 5 0.6)  106 cm2/s. They ultimately
conclude that ‘‘the true value [is] most likely toward the up-
per end of this range,’’ because the lower values likely
reflect the effects of residual stratum corneum (SC) remain-
ing on tape-stripped epidermis.
Small hydrophilic permeants like water and moderately
lipophilic permeants like hydrocortisone lie at the in-
tersection of all the phenomena discussed. Both transmem-
brane and cytoplasmic resistance are significant in the
transcellular pathway, and the extracellular route also makes
a discernible contribution to solute flux. Moreover, transbi-
layer and gap junctional diffusion can both contribute
significantly to transmembrane transport. Thus, everything
is important, and one must resort to the full computational
model to calculate D
epi
. A model is only as reliable as
the parameters entering it, and experiments targeting
Diffusion Model of Viable Epidermis 2317microscopic phase-specific properties of the epidermis are
ultimately the only means of determining them definitively,
much more so than measurements of overall (average)
epidermal permeabilities (which reflect these parameters
only in an aggregate form). Although Table 1 is consistent
with available anecdotal information on average properties
(8,51), it represents a provisional statement subject to
revision.Use of the model
The ultimate outcome of our analysis is a computer code
that estimates K
epi=w
and D
epi
for the mobile fraction of
any solute based on its values of MW, Koct/w, Daq, and
PDMPC/w. The results can be slotted directly into the viable
epidermis layer of rigorous transient diffusion models of
dermal absorption (8–10). Thus, the two-scale program
can now be supported with a microscopic basis for predict-
ing mobile solute concentrations at specific sites within the
epidermis (e.g., in the extracellular fluid bathing the plasma
membrane of Langerhans cells in contact allergy applica-
tions). Because means of estimating PDMPC/w are available
(49), our model can be applied generally, and not only to
solutes for which this permeability coefficient has been
measured.
We distinguish spinous and granular layers in terms of
aspect ratio and occurrence of tight junctions, although a
macroscopic model might employ a single average layer
for simplicity. The basal (mono)layer differs fundamentally
from the spinous layer above it in terms of metabolism and
cell division, among a host of biological processes not
occurring elsewhere. However, at this level of description,
differences in passive permeability properties would owe
primarily to the higher aspect ratio of the cells of the former
(42). In the limit kTJ/N, which is representative of these
layers, the calculated D
epi
is quantitatively affected by, but
not overly sensitive to, keratinocyte aspect ratio (see Tables
4 and 5). Thus, little error in predictions of passive perme-
ability would likely result from subsuming the basal layer
into a thickened spinous layer.Scope of the model, and future directions
We consciously limited the scope of this investigation to
defining the basic passive transport properties of viable
epidermal tissue for the mobile fraction of permeating
solutes. As it stands, the theory applies only to small solutes
that are not excessively hydrophobic and therefore not
overly susceptible to protein binding. The goal was to estab-
lish the level of mobility attributable to passive diffusion
through the cellular structure. This is the baseline upon
which binding (and also metabolic) phenomena are
superposed.
The next logical step is the addition of solute binding to
elements of the microstructure, which include cytoplasmicstructures as well as albumin and other binding/transporter
proteins in both cytoplasm and extracellular fluid. Although
there is hope of developing general correlations for non-
specific binding properties along the lines of a recent
theoretical model of dermis (11), in many cases the treat-
ment of binding (and particularly metabolism) will likely
be highly permeant-specific.SUPPORTING MATERIAL
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